Veterinary Medicines

VETERELIN 0.004 mg/ml solution for injection for cattle, horses, pigs, and rabbits

Authorised
  • Buserelin
Download as PDF

Product identification

Medicine name:
VETERELIN 0.004 mg/ml solution for injection for cattle, horses, pigs, and rabbits
Veterelin 0,004 mg/ml oplossing voor injectie voor runderen, paarden, varkens en konijnen
Active substance:
  • Buserelin
Target species:
  • Cattle
  • Horse
  • Pig
  • Other Leporids
Route of administration:
  • Solution for injection

Product details

Active substance and strength:
  • Buserelin
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Solution for injection
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Other Leporids
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Colourless glass vials of 10 ml, with bromobutyl rubber closure and aluminium capsules with Flip-off opening ring in PP of blue colour. 5 Bottles of 10 ml.
  • Colourless glass vials of 20 ml, with bromobutyl rubber closure and aluminium capsules with Flip-off opening ring in PP of blue colour. 1 Bottle of 20 ml.
  • Colourless glass vials of 10 ml, with bromobutyl rubber closure and aluminium capsules with Flip-off opening ring in PP of blue colour. 1 Bottle of 10 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 108021
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/104/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • France
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 17/11/2021
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."